US equities |
SPCX $174.50 ▲+1.99% NVDA $242.15 ▲+1.36% MU $1,072.63 ▲+0.81% MRVL $295.98 ▲+9.12% AMD $643.14 ▲+1.80% SNDK $1,689.20 ▼-0.88% TSLA $380.27 ▲+0.41% META $738.92 ▼-0.40%
FinancialContent

Twist Bioscience Corporation - Common Stock (NQ:TWST)

205.84 +0.84 (+0.41%)
Delayed Quote Updated: 10:05 AM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday ↗
Cathie Wood-led Ark Invest made trades involving IRDM, TWST, PD, BEAM, ROKU, and IBTA. 
Via Benzinga
News headline image
Cathie Wood Dumps $16 Million Worth Of Palantir Stock After Record Highs ↗
On Monday, February 10, 2025, the Cathie Wood-led Ark Invest sold nearly $16 million worth of Palantir shares amid a spike in the share price of the company. 
Via Benzinga
News headline image
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday ↗
Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made. 
Via Benzinga
News headline image
Forecasting The Future: 6 Analyst Projections For Twist Bioscience ↗
 
Via Benzinga
News headline image
Top Wall Street Forecasters Revamp Twist Bioscience Price Expectations Ahead Of Q4 Earnings ↗
 
Via Benzinga
News headline image
Twist Bioscience Earnings Preview ↗
 
Via Benzinga
News headline image
Deep Dive Into Twist Bioscience Stock: Analyst Perspectives (5 Ratings) ↗
 
Via Benzinga
News headline image
Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Earnings Scheduled For February 3, 2025 ↗
 
Via Benzinga
News headline image
Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments ↗
Cathie Wood, founder and CEO of ARK Investment Management LLC, defended the future of artificial intelligence investments while highlighting Tesla Inc. as a cornerstone of technological innovation... 
Via Benzinga
Topics Artificial Intelligence
News headline image
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared? ↗
Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies. 
Via Benzinga
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Crude Oil Rises Sharply; US Homebuilder Sentiment Surges In November ↗
 
Via Benzinga
News headline image
Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps ↗
Twist Bioscience's Q4 results topped estimates, with revenue up 27% YoY. Fiscal 2025 guidance includes revenue growth and a targeted gross margin of 48%. 
Via Benzinga
News headline image
Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Earnings Scheduled For November 18, 2024 ↗
 
Via Benzinga
News headline image
Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500 ↗
The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings. 
Via Benzinga
Topics ETFs Stocks
News headline image
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
Collaboration brings together Absci’s Generative AI drug creation platform with Twist’s DNA synthesis platform to accelerate the design of a novel therapeutic antibody 
From Absci Corporation
Via GlobeNewswire
News headline image
Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer
From Twist Bioscience Corporation
Via Business Wire
News headline image
Coeur Mining, Medical Properties Trust And RH Are Among Top 7 Mid Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio? ↗
7 mid-cap stocks with impressive gains last week: CDE, MPW, NGD, RH, AUR, TWST, ALHC. Positive news and financial results drove the surge. 
Via Benzinga
News headline image
Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
From Twist Bioscience Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >